Mathes Company’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-2,950
Closed -$201K 170
2014
Q1
$201K Hold
2,950
0.11% 160
2013
Q4
$208K Buy
+2,950
New +$208K 0.11% 156